The DOI matches its Crossref record.
Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical studies with CrM have been largely positive in DMD/BMD [177,178,201], equivocal in myotonic dystrophy (type I and II) [202–204], and positive in mixed myopathy populations [201,205].”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [201]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 10
- Kissel JT, Mendell JR. Muscular dystrophy: historical overview and classification in the genetic era. Semin Neurol 1999;15:5–7.
- 10.1055/s-2007-972648 · DOI
- 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C · DOI · Paper page
- 10.1212/WNL.52.4.854 · DOI · Paper page
- 10.1212/WNL.43.5.876 · DOI
- 10.1212/WNL.37.1.165 · DOI
- 10.1016/0022-510X(93)90326-T · DOI · Paper page
- 10.1016/S0014-5793(98)01399-4 · DOI
- 10.1038/6568 · DOI · Paper page
- 10.1212/WNL.43.3_Part_1.520 · DOI
Cited by
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., Flanigan, K. M., Pestronk, A., Tawil, R., Wolfe, G. I., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21338 · Cited by 481
Facioscapulohumeral muscular dystrophy
Tawil, R., & Van Der Maarel, S. M. (2006) · Muscle & Nerve · doi:10.1002/mus.20522 · Cited by 441
Hespel, P., Op't Eijnde, B., Leemputte, M. V., Ursø, B., Greenhaff, P. L., Labarque, V., Dymarkowski, S., Hecke, P. V., & Richter, E. A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0625c.xd · Cited by 335
Pharmacological strategies for muscular dystrophy
Khurana, T. S., & Davies, K. E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1085 · Cited by 225
Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy
Tarnopolsky, M. A., Mahoney, D. J., Vajsar, J., Rodriguez, C., Doherty, T. J., Roy, B. D., & Biggar, D. (2004) · Neurology · doi:10.1212/01.wnl.0000125178.18862.9d · Cited by 216
Creatine for treating muscle disorders
Kley, R. A., Tarnopolsky, M. A., & Vorgerd, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub4 · Cited by 169
Effect of Oral Creatine Supplementation on Human Muscle GLUT4 Protein Content After Immobilization
Eijnde, B. O. '., Ursø, B., Richter, E. A., Greenhaff, P. L., & Hespel, P. (2001) · Diabetes · doi:10.2337/diabetes.50.1.18 · Cited by 162
Exploring the therapeutic role of creatine supplementation
Gualano, B., Artioli, G. G., Poortmans, J. R., & Lancha Junior, A. H. (2010) · Amino Acids · doi:10.1007/s00726-009-0263-6 · Cited by 156
Mitochondrial contact sites: their role in energy metabolism and apoptosis
Brdiczka, D. G., Zorov, D. B., & Sheu, S.-S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.007 · Cited by 150
Pharmacokinetics of the Dietary Supplement Creatine
Persky, A. M., Brazeau, G. A., & Hochhaus, G. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342060-00005 · Cited by 132
Beneficial effects of creatine supplementation in dystrophic patients
Louis, M., Lebacq, J., Poortmans, J. R., Belpaire‐Dethiou, M., Devogelaer, J., Van Hecke, P., Goubel, F., & Francaux, M. (2003) · Muscle & Nerve · doi:10.1002/mus.10355 · Cited by 130
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
Creatine transporter and mitochondrial creatine kinase protein content in myopathies
Tarnopolsky, M. A., Parshad, A., Walzel, B., Schlattner, U., & Wallimann, T. (2001) · Muscle & Nerve · doi:10.1002/mus.1055 · Cited by 80
Banerjee, B., Sharma, U., Balasubramanian, K., Kalaivani, M., Kalra, V., & Jagannathan, N. R. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.03.008 · Cited by 68
Kornblum, C., Schröder, R., Müller, K., Vorgerd, M., Eggers, J., Bogdanow, M., Papassotiropoulos, A., Fabian, K., Klockgether, T., & Zange, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00970.x · Cited by 65
Protective effects of oral creatine supplementation on spinal cord injury in rats
Hausmann, O., Fouad, K., Wallimann, T., & Schwab, M. (2002) · Spinal Cord · doi:10.1038/sj.sc.3101330 · Cited by 61
Creatine Supplementation in Children and Adolescents
Jagim, A. R., & Kerksick, C. M. (2021) · Nutrients · doi:10.3390/nu13020664 · Cited by 61
“…g dose 3×/day Morphological and eye function as- sessments ↔ Cr supple- mentation did not prevent normal deterio- ration; ↓ Muscle atro- phy, primarily in type II fibers None reported Walter et al. 2000 [59] 36 patients with multiple types of muscular dystro- phies (overall mean age: 26 ±…”
BackgroundInfluentialCreatine for treating muscle disorders
Kley, R. A., Vorgerd, M., & Tarnopolsky, M. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub2 · Cited by 45
Fairman, C. M., Kendall, K. L., Hart, N. H., Taaffe, D. R., Galvão, D. A., & Newton, R. U. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.11.003 · Cited by 43
Creatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
Creatine for treating muscle disorders
Kley, R. A., Tarnopolsky, M. A., & Vorgerd, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub3 · Cited by 38
(2018) · Europe PMC (PubMed Central) · Cited by 16
Hijikata, Y., Katsuno, M., Suzuki, K., Hashizume, A., Araki, A., Yamada, S., Inagaki, T., Ito, D., Hirakawa, A., Kinoshita, F., et al. (2018) · JMIR Research Protocols · doi:10.2196/resprot.8655 · Cited by 13
Metadata
- Authors
- Walter, M. C., Lochmüller, H., Reilich, P., Klopstock, T., Huber, R., Hartard, M., Hennig, M., Pongratz, D., & Müller–Felber, W.
- Affiliations
- From the Friedrich-Baur-Institute (Drs. WalterLochmüller, Reilich, Pongratz, and Müller–Felber), Departments of Neurology (Dr. Klopstock) and Pulmonology (Dr. Huber), Ludwig-Maximilians-University of Munich; and the Department of Sports Medicine (Dr. Hartard), Institute for Medical Statistics and Epidemiology (M. Hennig), Technical University of Munich, Germany.
- Venue
- Neurology
- Published
- 2000-05-09
- Volume
- 54
- Issue
- 9
- Pages
- 1848-1850
- ISSN
- 0028-3878
- 1526-632X
- Cited by
- 137
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
